IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting

Journal of Pathology

Volumn 221, Issue 3, 2010, Pages 300-307

  Hajdu, Mihai ^a   Singer, Samuel ^a   Maki, Robert G ^a   Schwartz, Gary K ^a   Keohan, Mary Lou ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

DDR1; Expression profiling; IGF2; Solitary fibrous tumour

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; SOMATOMEDIN B; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOMICS; HUMAN; HYPOGLYCEMIA; MALE; MOLECULAR IMPRINTING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; SOLITARY FIBROUS TUMOR;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; SOLITARY FIBROUS TUMORS;

EID: 77953528175     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2715     Document Type: Article

References (27)

1. Guillou L, Fletcher JA, Fletcher CDM, Mandahl N. Extrapleural solitary fibrous tumour and haemangiopericytoma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002.
2. Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al . Clinicopathological correlates of solitary fibrous tumors. Cancer 2002; 94: 1057-1068. (Pubitemid 34150861)
3. Park MS, Araujo DM. New insights into the hemangiopericytoma/ solitary fibrous tumor spectrum of tumors. Curr Opin Oncol 2009; 21: 327-331.
4. Zafar H, Takimoto CH, Weiss G. Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor. Med Oncol 2003; 20: 403-408.
5. Zapf J. Insulinlike growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Metab 1995; 6: 37-42.
6. Li Y, Chang Q, Rubin BP, Fletcher CD, Morgan TW, Mentzer SJ, et al . Insulin receptor activation in solitary fibrous tumours. J Pathol 2007; 211: 550-554. (Pubitemid 46502431)
7. Debiec-Rychter M, de Wever I, Hagemeijer A, Sciot R. Is 4q13 a recurring breakpoint in solitary fibrous tumors? Cancer Genet Cytogenet 2001; 131: 69-73. (Pubitemid 33081161)
8. Mandahl N, Orndal C, Heim S, Willen H, Rydholm A, Bauer HC, et al . Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer 1993; 71: 3009-3013. (Pubitemid 23145531)
9. Antonescu CR, Viale A, Sarran L, Tschernyavsky SJ, Gonen M, Segal NH, et al . Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomical site. Clin Cancer Res 2004; 10: 3282-3290. (Pubitemid 38685432)
10. Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, et al . Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 2003; 163: 691-700.
11. West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, et al . Determination of stromal signatures in breast carcinoma. PLoS Biol 2005; 3: e187.
12. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121. (Pubitemid 32397092)
13. Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, et al . KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res 2009; 69: 7175-7179.
14. Tadokoro K, Fujii H, Inoue T, Yamada M. Polymerase chain reaction (PCR) for detection of ApaI polymorphism at the insulin like growth factor II gene (IGF2). Nucleic Acids Res 1991; 19: 6967.
15. Lawson EA, Zhang X, Crocker JT, Wang WL, Klibanski A. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma. J Clin Endocrinol Metab 2009; 94: 2226-2231.
16. Landau M, Ben-Tal N. Dynamic equilibrium between multiple active and inactive conformations explains regulation and oncogenic mutations in ErbB receptors. Biochim Biophys Acta 2008; 1785: 12-31. (Pubitemid 350192080)
17. Loriaux MM, Levine RL, Tyner JW, Frohling S, Scholl C, Stoffregen EP, et al . High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. Blood 2008; 111: 4788-4796.
18. Rossi G, Schirosi L, Giovanardi F, Sartori G, Paci M, Cavazza A. Pleural malignant solitary fibrous tumor with sarcomatous over-growth showing PDGFRβ mutation. Chest 2006; 130: 581-583. (Pubitemid 44267032)
19. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, et al . Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
20. Dejeux E, Olaso R, Dousset B, Audebourg A, Gut IG, Terris B, et al . Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression. Endocr Relat Cancer 2009; 16: 939-952.
21. Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 2004; 13: 69-78. (Pubitemid 38072136)
22. Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, et al . Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci USA 2005; 102: 14344-14349.
23. Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, et al . Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 2008; 68: 664-673.
24. Freier K, Schwaenen C, Sticht C, Flechtenmacher C, Muhling J, Hofele C, et al . Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol 2007; 43: 60-66. (Pubitemid 46162249)
25. Acevedo VD, Ittmann M, Spencer DM. Paths of FGFR-driven tumorigenesis. Cell Cycle 2009; 8: 580-588.
26. Vogel W. Discoidin domain receptors: structural relations and functional implications. FASEB J 1999; 13(suppl): S77-82.
27. Matsuyama W, Watanabe M, Shirahama Y, Mitsuyama H, Higashimoto I, Osame M, et al . Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis. Am J Pathol 2006; 168: 866-877.